Showing results (791-800 of 1,007) with videos related to

Sort By:
Pageof 101
Journal of Clinical Psychopharmacology|June 20, 2024
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension StudyRobert A Hauser, Hadas Barkay, Hubert H Fernandez, et al.
Bulletin of Environmental Contamination and Toxicology|June 11, 2013
Polybrominated diphenyl ethers (PBDES) and polychlorinated biphenyls (PCBS) in mussels and two fish species from the estuary of the Guanabara Bay, Southeastern BrazilS F Gonçalves da Silva, I M R A Brüning, R C Montone, et al.
JAMA Neurology|June 13, 2017
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical TrialRajesh Pahwa, Caroline M Tanner, Robert A Hauser, et al.
European Journal of Immunology|December 11, 2020
Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study resultsIngeborg A Hauser, Stefanie Marx, Claudia Sommerer, et al.
Journal of Experimental Botany|August 29, 2025
Development of an efficient CRISPR-mediated genome editing platform in the diploid-polyploid model system Tragopogon (Asteraceae)Shengchen Shan, Michael T Pisias, Zhengzhi Zhang, et al.
Annals of Neurology|September 1, 1995
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's diseaseT B Freeman, C W Olanow, R A Hauser, et al.
Metallomics : Integrated Biometal Science|April 11, 2015
Disruption of zinc and copper interactions with Aβ(1-40) by a non-toxic, isoniazid-derived, hydrazone: a novel biometal homeostasis restoring agent in Alzheimer's disease therapy?R A Hauser-Davis, L V de Freitas, D S Cukierman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2010
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipientsA Humar, Y Lebranchu, F Vincenti, et al.
The New England Journal of Medicine|April 27, 1995
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's diseaseJ H Kordower, T B Freeman, B J Snow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2021
Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept TrialAleksandar Videnovic, Amy W Amara, Cynthia Comella, et al.
Pageof 101